The Honest Answers.

Daily Guidance lives in the app. If a signal needs attention, Laymen can send a short message that explains what changed, why it matters, what is missing, and what to do next.

No. The point is continuity, not engagement. Quiet weeks stay quiet. When something deserves attention, you get one clear message instead of streaks, badges, or noise.

No. Laymen is a health guidance system built from available signals. It does not diagnose, prescribe, or provide emergency care; medical decisions remain yours and your clinician's.

Genome is not generally available yet. We are treating it as the deepest context layer in Laymen, so it will not open until consent, encryption, review, and deletion controls are ready.

Not yet. The current Laymen app runs on iPhone and uses Apple Health. Android and Health Connect remain future platform work, with no announced launch date.

Tell us in onboarding or by replying. Laymen treats those contexts as important, may ask for more information, and will not contradict your care team.

Terms is free. Baseline subscriptions are available only in the current internal/TestFlight beta. They are not yet attached to an approved public App Store version or available to the public. Current beta prices, billing periods, and any trial terms are shown before purchase. Genome is not generally available yet.

Yes. Cancel through the purchase provider that manages your subscription. Deleting your Laymen account does not cancel an active subscription; cancel with the purchase provider first if renewal remains.

A small team in Boston with backgrounds in genomics, clinical informatics, and consumer software. We are building the missing health layer directly for people, which means the product has to win on usefulness, trust, and follow-through.